Rare diseases
Investigational molecules
Locations
Back to Poland1 013 clinical trials in Lodz, Poland across 17 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Comparison of zasocitinib and deucravacitinib in adults with moderate to severe plaque psoriasis
PolandStudy of IPN10200 compared to placebo for prevention of episodic or chronic migraine in adults
PolandStudy of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis
PolandStudy of TAK-279 and apremilast for adults with moderate to severe plaque psoriasis
PolandStudy of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
PolandStudy of rocatinlimab (AMG 451) in adolescents with moderate to severe atopic dermatitis to evaluate its effectiveness and safety over 52 weeks
PolandLong-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa
PolandStudy of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels
PolandStudy of NT 201 compared to placebo in adults with moderate to severe platysma prominence
PolandComparison of linaprazan glurate versus lansoprazole for healing of erosive esophagitis in adults with gastroesophageal reflux disease
PolandStudy of Ruxolitinib Cream for Children and Adolescents Ages 6-17 with Moderate Atopic Dermatitis Who Did Not Respond Well to Standard Treatments
PolandEvaluation of Ziltivekimab in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation
PolandThe busiest research cities in the country
What the registry says about research in the country
Ongoing clinical trials focusing on respiratory viral infections and preventive vaccines, particularly targeting RSV and influenza in older adults. Studies evaluate vaccine efficacy and immune responses to protect against severe respiratory diseases.
Multiple studies assess combination vaccines and co-administration strategies to enhance protection against multiple respiratory pathogens.
Innovative research examining treatments for plaque psoriasis and related conditions. Trials investigate novel therapeutic approaches including oral medications and biological treatments for moderate to severe cases.
Studies focus on measuring improvement in disease severity and quality of life outcomes for patients.
Comprehensive research on meningococcal and pneumococcal vaccines, with special attention to pediatric populations. Studies evaluate safety profiles and immune responses across different age groups.
Trials incorporate multiple age cohorts from infants to adolescents, ensuring comprehensive vaccine effectiveness data.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
